Group 1 - The core point of the article is that Taihe Co., Ltd. announced the convening of its fourth board meeting on November 20, 2025, to discuss the proposal for the third extraordinary shareholders' meeting in 2025 [1] - For the year 2024, the revenue composition of Taihe Co., Ltd. is as follows: pesticides account for 85.02%, functional chemicals account for 11.2%, and others account for 3.78% [1]

11月21日，中农联合跌5.01%，截至发稿，报16.87元/股，成交3541.21万元，换手率1.60%，总市值 24.04亿元。中农联合股价已经连续3天下跌，区间累计跌幅4.52%。 资料显示，山东中农联合生物科技股份有限公司位于中国(山东)自由贸易试验区济南片区经十路9999号 黄金时代广场A座14层，成立日期2006年12月19日，上市日期2021年4月6日，公司主营业务涉及农药原 药、中间体及制剂产品的研发、生产和销售。主营业务收入构成为：农药制剂52.97%，农药原药 44.83%，化工材料2.13%，其他0.07%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 从中农联合十大流通股东角度 数据显示，诺安基金旗下1只基金位居中农联合十大流通股东。诺安多策略混合A（320016）三季度新 进十大流通股东，持有股数93.2万股，占流通股的比例为0.73%。根据测算，今日浮亏损失约82.95万 元。连续3天下跌期间浮亏损失78.29万元。 诺 ...

Group 1 - The core viewpoint of the report indicates that while some chemical products have seen price rebounds, many others continue to decline, reflecting a mixed performance in the chemical industry [1][4] - Significant price increases this week include Toluene (up 25.22%), Liquid Chlorine (up 13.73%), Methylcyclosiloxane (up 13.64%), and Sulfuric Acid (up 11.11%) [2][4] - Conversely, notable price declines were observed in products such as Butadiene (down 7.89%), Vinyl Acetate (down 4.35%), and Fuel Oil (down 3.80%) [2][4] Group 2 - The chemical industry is currently experiencing a weak overall performance, with varying results across different sub-sectors, primarily due to past capacity expansions and weak demand [4] - The report suggests focusing on investment opportunities in Glyphosate, fertilizers, and sectors benefiting from domestic demand and high dividend yields [4] - Specific recommendations include companies like Jiangshan Co., Xingfa Group, and Yangnong Chemical in the Glyphosate sector, and Hualu Chemical, Xinyangfeng, and Yuntianhua in the fertilizer industry [4] Group 3 - The report highlights the potential for the Glyphosate industry to enter a favorable cycle due to decreasing inventory and recent price increases, especially as overseas markets begin to restock [4] - It also emphasizes the importance of selecting companies with strong competitive positions and growth potential, such as Ruifeng New Materials and Baofeng Energy [4] - In the context of declining international oil prices, the report favors companies with high asset quality and dividend yields, particularly Sinopec, which stands to benefit from lower raw material costs [3][4]

11月21日，长青股份跌5%，截至发稿，报6.08元/股，成交5723.07万元，换手率1.99%，总市值39.50亿 元。长青股份股价已经连续3天下跌，区间累计跌幅4.62%。 资料显示，江苏长青农化股份有限公司位于江苏省扬州市江都区文昌东路1006号，成立日期2001年1月4 日，上市日期2010年4月16日，公司主营业务涉及化学农药的生产、销售,目前产品包括除草剂、杀虫 剂、杀菌剂等三大系列共18种原药、69种制剂。主营业务收入构成为：除草剂50.88%，杀虫剂 37.75%，杀菌剂8.34%，服务业1.77%，其他0.87%，调节剂0.39%。 从基金十大重仓股角度 霍顺朝累计任职时间2年227天，现任基金资产总规模162.51亿元，任职期间最佳基金回报30.93%， 任 职期间最差基金回报0.48%。 叶天垚累计任职时间227天，现任基金资产总规模21.96亿元，任职期间最佳基金回报2.97%， 任职期间 最差基金回报0.05%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 ...

11月20日，广信股份跌1.41%，成交额9426.78万元。两融数据显示，当日广信股份获融资买入额 1265.89万元，融资偿还663.59万元，融资净买入602.30万元。截至11月20日，广信股份融资融券余额合 计2.69亿元。 融资方面，广信股份当日融资买入1265.89万元。当前融资余额2.68亿元，占流通市值的2.48%，融资余 额低于近一年10%分位水平，处于低位。 截至9月30日，广信股份股东户数1.91万，较上期增加24.31%；人均流通股47778股，较上期减少 19.56%。2025年1月-9月，广信股份实现营业收入26.63亿元，同比减少23.69%；归母净利润5.20亿元， 同比减少9.36%。 分红方面，广信股份A股上市后累计派现25.03亿元。近三年，累计派现16.37亿元。 机构持仓方面，截止2025年9月30日，广信股份十大流通股东中，招商核心竞争力混合A（014412）位 居第四大流通股东，持股2248.37万股，持股数量较上期不变。华夏行业景气混合A（003567）位居第五 大流通股东，持股1849.23万股，持股数量较上期不变。香港中央结算有限公司位居第七大流通股东， ...

Group 1 - The core point of the news is that Limin Co., Ltd. experienced a decline in stock price and trading volume on November 20, with a drop of 3.89% and a transaction amount of 431 million yuan [1] - On November 20, Limin Co., Ltd. had a financing buy-in amount of 44.83 million yuan and a financing repayment of 64.24 million yuan, resulting in a net financing buy of -19.41 million yuan [1] - As of November 20, the total balance of margin trading for Limin Co., Ltd. was 470 million yuan, accounting for 5.95% of its circulating market value [1] Group 2 - As of November 10, the number of shareholders of Limin Co., Ltd. was 61,000, a decrease of 2.35% from the previous period, while the average circulating shares per person increased by 2.41% to 6,599 shares [2] - For the period from January to September 2025, Limin Co., Ltd. achieved an operating income of 3.599 billion yuan, representing a year-on-year growth of 7.62%, and a net profit attributable to the parent company of 390 million yuan, a significant increase of 661.66% [2] - Since its A-share listing, Limin Co., Ltd. has distributed a total of 919 million yuan in dividends, with 321 million yuan distributed in the last three years [2]

Core Points - The company announced that all guarantees are mutual guarantees between the company and its wholly-owned subsidiaries [2] - The company and its wholly-owned subsidiaries have not experienced overdue external guarantees, litigation-related guarantees, or guarantee losses due to adverse judgments [2]

证券日报网讯 11月20日晚间，利民股份发布公告称，全资子公司利民化学有限责任公司于近日收到江 苏省生态环境厅下发的《关于利民化学有限责任公司年产100吨新型高效多功能植保原药技改项目环境 影响报告书的批复》（苏环审【2025】90号）。 （文章来源：证券日报） ...

Core Viewpoint - Xingfa Group's glyphosate production capacity is currently at 230,000 tons per year, with an overall operating rate exceeding 80% [2] Company Summary - The total production capacity of glyphosate facilities is 230,000 tons per year [2] - The overall operating rate of the facilities is more than 80% [2] Industry Summary - The glyphosate production capacity and operating rates indicate a strong performance in the agricultural chemicals sector [2]

Group 1 - EVE Energy signed a procurement framework agreement with its affiliate, Smoore International, for continuous procurement of battery cells starting from January 1, 2026 [1] - Zhaoyi Information plans to issue H-shares and list on the Hong Kong Stock Exchange [1] - Fuke Environmental announced a change in its stock abbreviation to "Fuke Technology" effective November 26 [1] Group 2 - Dajia Weikang's shareholder and director terminated a share reduction plan ahead of schedule, having reduced 1% of total shares [2] - Aohong Electronics received approval from the China Securities Regulatory Commission for the issuance of convertible bonds [2] - Yingfeng Environment's controlling shareholder plans to issue exchangeable bonds not exceeding 1 billion yuan [2] Group 3 - Longshen Rongfa's subsidiary obtained a renewed drug production license covering various pharmaceutical products [4] - Xinhua News' subsidiary invested 15 million yuan in a fund with a total commitment of 221 million yuan [5] - Guang'an Aizhong appointed two new deputy general managers [6] Group 4 - Fosun Pharma's subsidiary's drug for gastric cancer treatment was included in the breakthrough therapy program by the National Medical Products Administration [7] - Nanjiao Foods reported a significant decline in October net profit due to rising raw material costs [8] - Nanfeng Co. won two nuclear power project bids totaling 928.7 million yuan [10] Group 5 - Puluo Pharmaceutical received a drug registration certificate for its Cefdinir capsules [11] - Liming Co.'s subsidiary received environmental approval for a new pesticide raw material project [12] - Longhua New Materials' expansion project for polyether polyols has commenced trial production [13] Group 6 - Pumen Technology's products received IVDR CE certification from TÜV Rheinland [15] - China Chemical reported new contracts worth 312.67 billion yuan from January to October [18] - China Nuclear Construction achieved new contracts totaling 123.84 billion yuan as of October [19] Group 7 - Changshu Bank's executives plan to purchase at least 550,000 shares of the bank [20] - Shandong Steel's subsidiary is applying for bankruptcy liquidation to focus on core business [21] - Huakang Clean is expected to win a bid for a purification system project worth 176 million yuan [23] Group 8 - Huawu Co. plans to internally transfer subsidiary equity [24] - Tianen Kang's subsidiary received clinical trial acceptance for a new drug [26] - Tianyi Medical's subsidiary obtained a medical device registration certificate for a blood dialysis product [27] Group 9 - Xuelang Environment is facing a pre-restructuring application from creditors [27] - Chitianhua's subsidiary resumed production after passing safety inspections [28] - Huaping Co.'s director plans to reduce 0.03% of company shares [30] Group 10 - Xizhuang Co. plans to establish a wholly-owned subsidiary in Singapore [31] - Ruisheng Intelligent's subsidiary won a 60.23 million yuan ICT project bid [32] - Junyi Digital plans to invest 120 million yuan in Guanghong Precision [33] Group 11 - Fuguang Co.'s controlling shareholder plans to increase holdings between 80 million to 150 million yuan [34] - Ganyue Express reported a 13.68% increase in logistics revenue in October [39] - Jiangsu Sop terminated its 2025 private placement plan [41] Group 12 - Langke Intelligent's shareholders plan to reduce a total of 1.68% of company shares [42] - Yuantong Express reported an 8.97% increase in express product revenue in October [45] - Jinbei Automotive plans to invest 158 million yuan to acquire 52% of Zhongtuo Technology [46]